Research Funding – Call for Proposals

Funding Agency:
Brain Foundation

At The BRAIN Foundation, our primary focus is catalyzing basic and interdisciplinary translational research that leads to the development of effective therapeutics to improve the functioning of individuals with Neuro-Developmental Disorders (NDD) including Autism Spectrum Disorders (ASD).

This includes translational research leading to breakthroughs in understanding and characterization of the pathophysiology of autism, basic science research, the discovery of biomarkers and therapeutic targets for one or more symptoms, drug repurposing, and development of novel drug compounds, devices, and other related areas.

We believe that the most effective use of our funds is to target high-need and high-impact yet under-served areas of focus within the landscape of investments in research. In that vein, every year, the BRAIN Foundation puts forth a Request for Proposals for grants for research in our focus areas to benefit individuals with NDD, including ASD.

This year, we invite researchers, fellows, post-doctoral scholars and students to submit proposals.

Deadline: Aug. 1, 2023

Agency Website

Areas of Interest

Areas of research include (but not limited to): 



Developing biological biomarkers to improve diagnostics and treatment response.


Immune-abnormalities in autism:

Funding studies to characterize the altered immune response in autism.


Gut dysfunction in autism:

Studies to characterize GI pathology in autism. Exploring diagnostic and treatment strategies.


Epilepsy in autism:

Studies to investigate etiology, triggers, risk factors, warning signs and treatments. Exploring prevalence and impact of subclinical seizure activity in autism. Investigate the need and scope for changes in standard of care.


Speech, motor and behavior in autism: 

Studies to determine etiology and treatments for functional impairments in speech, language processing, motor skills, executive function and severely disabling behaviors such as aggression and self-injury.


Treatment trials:

Phase I/II clinical treatment trials to evaluate efficacy of new compounds and repurposed drugs for treatment of disabling symptoms of autism.


Case studies and retrospective analyses: 

Research related to a retrospective analysis of medical records, publication of case studies etc.

Eligibility Requirements

A PI associated with a research institution or private enterprise who can work with their organization to accept a grant from a non-profit and obtain an IRB for their work, if needed.



Amount Description

Our maximum budget is $90K per year, for a maximum 2 year grant.

Funding Type



Grad/Prof Students
Medical Fellow/Resident
Post Doctoral Fellows


Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

August 1, 2023